Benzinga's Top #PreMarket Gainers
January 09, 2014 at 08:14 AM EST
Intercept Pharmaceuticals (NASDAQ: ICPT ) shares jumped 119.43% to $159.00 in pre-market trading after the company reported that the FLINT trial of obeticholic acid has been stopped early and the NASH primary endpoint has been met. Sangamo Biosciences (NASDAQ: SGMO ) shares gained 13.64% to $15.50 in the pre-market